Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Aclidinium bromide/formoterol
Подписчиков: 0, рейтинг: 0
Combination of | |
---|---|
Aclidinium bromide | Long-acting muscarinic antagonist |
Formoterol | Long-acting β2 agonist |
Clinical data | |
Trade names | Brimica Genuair, Duaklir Genuair, Duaklir Pressair |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Pregnancy category |
|
Routes of administration |
Inhalation |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.
External links
- "Aclidinium bromide". Drug Information Portal. U.S. National Library of Medicine.
- "Formoterol fumarate". Drug Information Portal. U.S. National Library of Medicine.
α1 |
|
||||
---|---|---|---|---|---|
α2 |
|
||||
β |
|
||||
mAChRs |
|
||||
---|---|---|---|---|---|
Precursors (and prodrugs) |
|||||